Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GBNH Greenbrook TMS (GBNH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Greenbrook TMS Stock (NASDAQ:GBNH) 30 days 90 days 365 days Advanced Chart Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Greenbrook TMS alerts:Sign Up Key Stats Today's Range$0.04▼$0.1050-Day Range$0.05▼$0.3852-Week Range$0.10▼$1.82Volume787,000 shsAverage Volume3.60 million shsMarket Capitalization$1.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGreenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.Read More… Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Receive GBNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter. Email Address GBNH Stock News HeadlinesGreenbrook TMS Strategic Acquisition and Restructuring by NeuroneticsNovember 22 at 2:26 AM | markets.businessinsider.comNeuronetics Sees Q3 Revenue Rise Amid Strategic AcquisitionNovember 13, 2024 | markets.businessinsider.comTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… November 24, 2024 | Crypto 101 Media (Ad)Neuronetics stockholders approve acquisition of Greenbrook TMSNovember 12, 2024 | markets.businessinsider.comGreenbrook TMS Shareholders Approve Neuronetics AcquisitionNovember 12, 2024 | markets.businessinsider.comNeuronetics Agrees To Acquire Greenbrook In All-stock TransactionAugust 12, 2024 | markets.businessinsider.comGBNHF Greenbrook TMS Inc.May 5, 2024 | seekingalpha.comGreenbrook TMS Inc. Announces Delisting From NasdaqFebruary 23, 2024 | finanznachrichten.deSee More Headlines GBNH Stock Analysis - Frequently Asked Questions How were Greenbrook TMS's earnings last quarter? Greenbrook TMS Inc. (NASDAQ:GBNH) released its quarterly earnings results on Monday, August, 14th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.29) by $0.01. The company earned $18.35 million during the quarter, compared to the consensus estimate of $19.15 million. What other stocks do shareholders of Greenbrook TMS own? Based on aggregate information from My MarketBeat watchlists, some other companies that Greenbrook TMS investors own include RENN Fund (RCG), Aceragen (ACGN), Alimera Sciences (ALIM), Alpine Summit Energy Partners (ALPS), Angion Biomedica (ANGN), AirNet Technology (ANTE) and Aptorum Group (APM). Company Calendar Last Earnings8/14/2023Today11/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:GBNH CUSIPN/A CIK1735948 Webwww.greenbrooktms.com Phone(416) 928-6076FaxN/AEmployees492Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-61,730,000.00 Net Margins-83.19% Pretax Margin-83.55% Return on EquityN/A Return on Assets-66.59% Debt Debt-to-Equity RatioN/A Current Ratio0.47 Quick Ratio0.47 Sales & Book Value Annual Sales$69.10 million Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value($1.72) per share Price / Book-0.03Miscellaneous Outstanding Shares40,800,000Free Float31,959,000Market Cap$1.96 million OptionableNot Optionable Beta2.19 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NASDAQ:GBNH) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenbrook TMS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenbrook TMS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.